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RNA-interactome capture’’ to analyze the
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infection. More than 200 cellular RNA-
binding proteins change their binding
activity in response to this challenge,
mainly driven by transcript availability.
Many of these RNA-binding proteins
regulate viral replication and can be
targeted to influence infection outcome.
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The compendium of RNA-binding proteins (RBPs)
has been greatly expanded by the development
of RNA-interactome capture (RIC). However, it re-
mained unknown if the complement of RBPs
changes in response to environmental perturbations
and whether these rearrangements are important. To
answer these questions, we developed ‘‘compara-
tive RIC’’ and applied it to cells challenged with an
RNA virus called sindbis (SINV). Over 200 RBPs
display differential interaction with RNA upon SINV
infection. These alterations are mainly driven by the
loss of cellular mRNAs and the emergence of viral
RNA. RBPs stimulated by the infection redistribute
to viral replication factories and regulate the capacity
of the virus to infect. For example, ablation of XRN1
causes cells to be refractory to SINV, while GEMIN5
moonlights as a regulator of SINV gene expression.
In summary, RNA availability controls RBP localiza-
tion and function in SINV-infected cells.
INTRODUCTION
RNA-binding proteins (RBPs) assemble with RNA forming ribo-
nucleoproteins (RNPs) that dictate RNA fate (Glisovic et al.,
2008). Historically, most of the known RBPs were characterized
by the presence of well-established RNA-binding domains196 Molecular Cell 74, 196–211, April 4, 2019 ª 2019 The Authors. P
This is an open access article under the CC BY license (http://creative(RBDs), which include the RNA recognition motif, K-homology
domain, and others (Lunde et al., 2007). However, stepwise iden-
tification of unconventional RBPs evoked the existence of a
broader universe of protein-RNA interactions than previously
anticipated (Castello et al., 2015). Recently, a system-wide
approach termed RNA-interactome capture (RIC) has greatly
expanded the compendium of RBPs (RBPome) (Hentze et al.,
2018). RIC employs UV crosslinking, oligo(dT) capture under
denaturing conditions, and quantitative proteomics to identify
the complement of proteins interacting with polyadenylated
(poly(A)) RNA in living cells (Baltz et al., 2012; Castello et al.,
2012). RIC uncovered hundreds of unconventional RBPs,
several of which are now known to play crucial roles in cell
biology (Hentze et al., 2018). Recent work has suggested that
cells can adapt to physiological cues through discrete alterations
in the RBPome (Perez-Perri et al., 2018; Sysoev et al., 2016).
However, it remains unknown to what extent the RBPome can
be remodeled, how RBP responses are triggered, and what
are the biological consequences of this plasticity. For example,
RIC reported changes in the composition of the RBPome during
fruit fly embryo development that could be explained by match-
ing alterations in protein abundance (Sysoev et al., 2016).
However, several RBPs did not follow this trend, displaying pro-
tein-level independent changes in RNA binding and raising the
question of whether physiological perturbations can induce
such responsive behavior more widely. To address this possibil-
ity, we developed a ‘‘comparative RIC’’ (cRIC) approach to pro-
file with high accuracy RBP dynamics in cells infected with
sindbis virus (SINV) (Figures 1A and 1B).
Viruses have been fundamental for the discovery and charac-
terization of important steps of cellular RNA metabolism such asublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. Application of RIC to HEK293 Cells Infected with SINV
(A) Schematic representation of cRIC.
(B) Schematic representation of SINV and chimeric SINV-mCherry genomes.
(C) Analysis of the proteins synthesized in uninfected and SINV-infected HEK293 cells by [35S]-Met/Cys incorporation for 1 h followed by autoradiography.
(D) Analysis of total and phosphorylated eIF2a by western blotting.
(legend continued on next page)
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RNA splicing, nuclear export, and translation initiation. This is
due to their ability to hijack key cellular pathways by interfering
with the activity of master regulatory proteins (Akusjarvi, 2008;
Carrasco et al., 2018; Castello´ et al., 2011; Garcia-Moreno
et al., 2018; Lloyd, 2015). Furthermore, specialized RBPs are
at the frontline of cellular antiviral defenses, detecting path-
ogen-associated molecular patterns (PAMPs) such as double-
stranded RNA (dsRNA) or RNAs with 50 triphosphate ends
(Barbalat et al., 2011; Vladimer et al., 2014). Hence, virus infected
cells represent an optimal scenario to assess the RBPome
rearrangements.
Our data show that the complement of active cellular RBPs
strongly changes in response to SINV infection, mainly due to
deep variations in RNA availability. Importantly, ‘‘altered’’ RBPs
are critical, as their perturbation affects viral fitness or/and the
ability of the cell to counteract the infection. We envision that
these RBPs represent novel targets for host-based antiviral
therapies.
RESULTS AND DISCUSSION
Applying RIC to Cells Infected with SINV
To study the dynamics of cellular RBPs in response to physiolog-
ical cues, we challenged cells with a cytoplasmic RNA virus and
applied RIC. We chose SINV and HEK293 cells as viral and
cellular models, respectively. SINV is a highly tractable virus
that is transmitted from mosquito to vertebrates, causing high
fever, arthralgia, malaise, and rash in humans. SINV replicates
in the cytoplasm of the infected cell and produces three viral
RNAs (Figures 1B and S1A): genomic RNA (gRNA), subgenomic
RNA (sgRNA), and negative-stranded RNA. gRNA is packaged
into the viral capsid and is translated to produce the nonstructural
proteins (NSPs) that form the replication complex. The sgRNA is
synthesized froman internal promoter andencodes the structural
proteins (SPs), which are required to generate the viral particles.
The negative strand serves as a template for replication. Both
gRNA and sgRNA have cap and poly(A) tail.
HEK293 cells are an excellent cellular model to study SINV, as
its infection exhibits all the expected molecular signatures,
including (1) active viral replication (Figures 1C, S1B, and S1C),
(2) host protein synthesis shutoff while viral proteins are
massively produced (Figures 1C and S1B), (3) phosphorylation
of the eukaryotic initiation factor 2 subunit alpha (EIF2a) (Fig-
ure 1D), and (4) formation of cytoplasmic foci enriched in viral
RNA and proteins, commonly known as viral replication factories
(Figures S1C and S1D). SINV infection causes a strong induction
of the antiviral program, including b-interferon (b-IFN), which
reflects the existence of active antiviral sensors and effectors
(Figure S1E). Importantly, SINV achieves infection in a high
proportion of cells (85%) with relatively low number of viral par-
ticles (MOI) (Figure S1F), reducing cell-to-cell variability and bio-
logical noise.(E) Silver staining analysis of the ‘‘inputs’’ (i.e., total proteome, left) and eluates (i
(F) qRT-PCR analysis of the eluates of a representative RIC experiment using sp
Error bars represent SE.
hpi, hours post-infection; MW, molecular weight.
See also Figure S1.
198 Molecular Cell 74, 196–211, April 4, 2019Pilot RIC experiments in uninfected and SINV-infected cells
revealed the isolation of a protein pool matching that previously
observed for human RBPs (Castello et al., 2012), which strongly
differed from the total proteome (Figure 1E). No proteins were
detected in nonirradiated samples, demonstrating the UV de-
pendency of RIC. Infection did not induce major alterations in
the protein pattern observed by silver staining, which corre-
spond to the most abundant housekeeping RBPs (Figure 1E).
However, other less predominant bands displayed substantial
differences, calling for in-depth proteomic analysis. Oligo(dT)
capture led to the isolation of both host and SINV RNAs in in-
fected cells (Figure 1F), which is expected as gRNA and sgRNA
are polyadenylated.
SINV Infection Alters the Activity of Hundreds of RBPs
To allow accurate quantification of RBPs associated with poly(A)
RNA under different physiological conditions, we developed a
cRIC approach by combining the original protocol (Castello
et al., 2013) with stable isotope labeling by amino acids in cell
culture (SILAC) (Figure 1A). In brief, cells were grown in presence
of light, medium, or heavy amino acids with incorporation
efficiency >98%. Labeled cells were infected with SINV and irra-
diated with UV light at 4 and 18 h post-infection (hpi), using un-
infected cells as a control (Figure 1A). These times correlate
with key states in the SINV biological cycle; i.e., at 4 hpi, viral
gene expression coexists with host protein synthesis, while the
proteins synthesized at 18 hpi are almost exclusively viral (Fig-
ure 1C). SILAC labels were permutated among uninfected,
4 hpi, and 18 hpi in the three biological replicates to correct for
possible isotope-dependent effects. After lysis, aliquots were
stored for parallel transcriptomic and whole-proteome analyses.
We combined equal amounts of the lysates from the three con-
ditions prior to the oligo(dT) capture, and eluates were analyzed
by quantitative proteomics (Figure 1A). Protein intensity ratios
between condition pairs were computed, and the significance
of each protein intensity change was estimated using a moder-
ated t test (Figures 2A–2D, S2A, and S2B). We used a semiquan-
titative method for the cases in which an intensity value was
missing (‘‘zero’’) in one of the two conditions leading to ‘‘infinite’’
or zero ratios (Sysoev et al., 2016).
We identified a total of 794 proteins, 91% of which were
already annotated by the Gene Ontology term ‘‘RNA-binding’’
or/and previously reported to be RBPs in eukaryotic cells by
RIC (Hentze et al., 2018). Hence, the protein composition of
our dataset largely resembles that of previously established
RBPomes. Only 17 proteins displayed differential interaction
with RNA at 4 hpi (Figures 2A, 2B, and S2A; Table S1). Fifteen
of these were detected exclusively by the semiquantitative
method due to the lack of intensity value in one condition, reflect-
ing possible ‘‘on-off’’ and ‘‘off-on’’ states (Table S1). By contrast,
236 RBPs displayed altered RNA-binding activities at 18 hpi (Fig-
ures 2C, 2D, and S2B; Table S1). A total of 247 RBPs displayed.e., RBPome, right) of a representative RIC experiment in SINV-infected cells.
ecific primers against SINV RNAs, actb and gapdh (for normalization) mRNAs.
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Figure 2. Analysis of the RNA-Bound Proteome in SINV-Infected HEK293 Cells by cRIC
(A) Scatterplot showing the intensity ratio between 4 hpi and uninfected conditions of each protein (dots) in the eluates of two biological replicates of cRIC.
(B) Volcano plot showing the log2 fold change and the significance (p value) of each protein between 4 hpi and uninfected conditions using data from three
biological replicates.
(C) As in (A) but for 18 hpi.
(D) As in (B) but for 18 hpi.
(E) Western blotting analysis with specific antibodies of the eluates of a representative RIC experiment in SINV-infected HEK293 cells.
(F) Molecular function (top) and cellular component (bottom) Gene Ontology (GO) term enrichment analysis of the stimulated (salmon) against inhibited (blue)
RBPs (18 hpi).
(G) Representative scatterplot comparing the raw intensity of each protein in the eluates of two cRIC replicates at 18 hpi.
FDR, false discovery rate; n.s., non-significant.
See also Figure S2 and Table S1.differential binding in infected cells (4 and 18 hpi) and are referred
to here as ‘‘altered RBPs.’’ Interestingly, 181 of these lack clas-
sical RBDs, highlighting the importance of unconventional RBPs
in virus infection.To validate these results, we applied RIC to cells infected with
SINV but, in this case, the eluateswere analyzed bywestern blot-
ting. We selected nine altered RBPs falling into three statistical
categories; i.e., four with 1% false discovery rate (FDR), fourMolecular Cell 74, 196–211, April 4, 2019 199
with 10% FDR, and one with nonsignificant changes. We
included a positive control (the viral RBP SINV capsid [C]), two
‘‘non-altered’’ RBPs (MOV10 and EPRS), and a negative control
(b-actin [ACTB]). Strikingly, the RNA-binding behavior of each
protein fully matched the proteomic outcome, including those
classified with 10% FDR (Figure 2E). Changes in RNA binding
increased progressively throughout the infection. The proteomic
data assigned a nonsignificant downregulation to HNRNPR
(Table S1); however, the reduced activity of this protein was
apparent by western blotting (Figure 2E), suggesting that our da-
taset may contain false negatives. Nonetheless, the excellent
agreement between the proteomic and western blotting data
supports the high quality of our results.
Determination of the RBP Networks Altered by SINV
Infection
Among the 247 altered RBPs, 133 presented reduced and 114
increased association with RNA, and they are here referred to
as ‘‘inhibited’’ and ‘‘stimulated’’ RBPs, respectively. Most of
the inhibited RBPs were linked to nuclear processes such as
RNA processing and export (Figures 2F and S2C). While cyto-
plasmic viruses are known to hamper nuclear RNA metabolism,
the mechanisms by which this occurs remain poorly understood
(Castello´ et al., 2011; Gorchakov et al., 2005; Lloyd, 2015).
Whether the inhibition of nuclear RBPs contributes to this phe-
nomenon should be further investigated. Conversely, a large
proportion of the stimulated RBPs are cytoplasmic and are
linked to protein synthesis, 50 to 30 RNA degradation, RNA trans-
port, protein metabolism, and antiviral response (Figures 2F
and S2D).
Interestingly, several RBPs involved in translation were stimu-
lated at 18 hpi despite the shutoff of host protein synthesis (Fig-
ure 1C), including 9 eukaryotic initiation factors, 3 elongation
factors, and 12 ribosomal proteins. This enhancement is likely
due to the high translational activity of SINV RNAs (Figure 1C)
(Frolov and Schlesinger, 1996). The core components of the
cap-binding complex EIF4A1 and EIF4E were not stimulated
by the infection despite the activation of their protein partner,
EIF4G1 (Table S1). In agreement, EIF4A1 and EIF4E do not
participate in SINV sgRNA translation (Carrasco et al., 2018).
A recent report showed that EIF3D is a cap-binding protein
that controls the translation of specific mRNA pools (Lee et al.,
2016). EIF3D is stimulated by SINV, and thus its potential contri-
bution to SINV RNA translation deserves further consideration.
Importantly, 88 altered RBPs associate with ribosomes in mouse
cells (Table S2) (Simsek et al., 2017). The existence of ‘‘special-
ized ribosomes’’ has been proposed; however, experimental ev-
idence is sparse (Au and Jan, 2014). Our results indicate that the
composition of ribosomes and the scope of proteins associated
with them may strongly differ between infected and uninfected
cells, possibly resulting in differential translational properties.
cRIC uncovered 16 altered RNA helicases (Table S2), 13 of
which were inhibited upon infection. RNA helicases are funda-
mental at virtually every stage of RNA metabolism (Chen and
Shyu, 2014), and their inhibition is expected to have important
consequences in RNA metabolism. Only 3 helicases were stim-
ulated by SINV (DDX1, DHX57, and DHX29) (Figure 2E; Table
S2). DHX29 enhances 48S complex formation on SINV sgRNA200 Molecular Cell 74, 196–211, April 4, 2019in reconstituted in vitro systems (Skabkin et al., 2010), and its
stimulation supports its regulatory role in infected cells.
Notably, a defined subset of antiviral RBPs is stimulated upon
SINV infection, including IFI16, IFIT5, TRIM25, TRIM56, and
ZC3HAV1 (ZAP) (Table S1). IFI16 was previously described to
bind dsDNA in cells infected with DNA viruses (Ni et al., 2016).
Our data reveal that IFI16 also binds RNA, and it is activated early
after SINV infection (4 hpi). This agrees with the recently
described ability of IFI16 to restrict RNA virus infection (Thomp-
son et al., 2014). These findings highlight the capacity of cRIC to
identify antiviral factors responding virus infection.
Interestingly, cRIC also identified viral RBPs associated with
poly(A) RNA, including the known viral RBPs (i.e., RNA helicase
NSP2, the RNA polymerase NSP4, and capsid) and, unexpect-
edly, also NSP3 and E2 (Figures 2G and S2E). NSP3 was only
quantified in two replicates (Figure S2E), and thus its interaction
with RNA requires experimental confirmation. The identification
of E2 in cRIC eluates was unexpected. In the viral particle of
the related VEEV, E2 interacts with the capsid protein nearby
cavities that communicate with the inner part of the virion where
the gRNA density resides (Zhang et al., 2011), potentially
enabling transitory or stochastic interactions with viral RNA.
RBP Responses to SINV Are Not Caused by Changes in
Protein Abundance
Changes detected by cRIC can be a consequence of matching
alterations in protein abundance (Sysoev et al., 2016). To assess
this possibility globally, we analyzed the total proteome by quan-
titative proteomics (cRIC inputs; Figure 1A). Importantly, SINV
infection did not cause noticeable changes in host RBP levels,
including 129 RBPs with altered RNA-binding activity (Figures
3A–3C and S3A–S3C; Table S3). In agreement, silver and Coo-
massie staining did not show noticeable protein fluctuations
except for the viral capsid (Figure 1E and 3D). The lack of
changes in protein levels, even for altered RBPs, was confirmed
by western blotting (Figure 3E; Table S3). It is not wholly unex-
pected that RBPs are unaffected in spite of the shutoff of cellular
protein synthesis. Analogous to siRNA experiments, detectable
decreases in protein abundance may require hours or even
days after translational suppression, especially for relatively sta-
ble proteins.
The Transcriptome Undergoes Pervasive Changes in
SINV-Infected Cells
Mechanistically, the activity of host RBPs can also be dictated by
changes in the availability of their target RNAs. To test this pos-
sibility, we analyzed by RNA sequencing (RNA-seq) the total
RNA isolated from cRIC input samples (Figure 1A). 4 h of SINV
infection had a relatively minor impact on the host transcriptome
(Figure 3F). By contrast, deep changes were observed at 18 hpi,
with 12,372 differentially expressed RNAs (p < 0.1; Figures 3G
and S3E–S3G). Only 1,448 RNAs were upregulated, and these
were enriched in the Gene Ontology (GO) term ‘‘antiviral
response.’’ By contrast, 10,924 RNAs were downregulated,
including many housekeeping genes (Table S4).
To validate these results by an orthogonal approach, we
used qRT-PCR focusing on 20 mRNAs randomly chosen
across the whole variation range. Importantly, data obtained
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Figure 3. Proteomic and Transcriptomic Analyses of Whole SINV-Infected Cell Lysates
(A) Scatterplot comparing the intensity ratio between 4 hpi and uninfected conditions of each protein (dots) in the inputs (total proteome) of two biological
replicates of cRIC. Black dots represent proteins significantly enriched in either 4 hpi or uninfected conditions in Figure 2A.
(B) As in (A) but for 18 hpi.
(C) Scatterplot comparing the intensity of each protein in the inputs of two cRIC replicates at 18 hpi.
(D) Representative Coomassie blue staining of cells infected with SINV.
(E) Western blotting analysis of lysates of cells infected with SINV (see Table S3 for quantification).
(F) MA plot comparing the read coverage and the log2 fold change between 4 hpi and uninfected cells of each gene detected in the RNA sequencing (RNA-seq)
experiment. Red dots represent RNAs enriched with p < 0.1.
(G) As in (F) but for 18 hpi.
(H) Correlation of the RNA-seq and RT-qPCR data by plotting the log2 fold change for randomly selected transcripts by the twomethods. Error bars represent SE
of three independent experiments.
See also Figure S3 and Tables S3 and S4.
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Figure 4. Host RBP Localization in SINV-Infected Cells
(A) RNA-seq read coverage of the positive and negative RNA strand of SINV. Note that the y axes in both plots have different scales.
(B) Localization analysis of SINV RNA and capsid protein in infected HeLa cells at 18 hpi by combined in situ hybridization and immunofluorescence.
(legend continued on next page)
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with both techniques strongly correlated (R2 = 0.82) (Figure 3H),
confirming the RNA-seq results. The decreased availability of
cellular RNA could explain why 133 RBPs display reduced
association with poly(A) RNA in infected cells (Table S1).
In addition, inhibited RBPs could exchange poly(A) mRNA
for non-poly(A) RNAs, which are not captured by the
oligo(dT) beads.
Stimulated RBPs Are Relocated to the Viral Replication
Factories
SINV produces two overlapping mRNAs, gRNA and sgRNA (Fig-
ures 1B and S1A), and, consequently, the read coverage was
substantially higher in the last third of the gRNA, where both tran-
scripts overlap (Figure 4A). Both sgRNA and gRNA have poly(A)
and thus should contribute to the cRIC results (Figures 4A and
S4A). Conversely, the negative strand has low abundance and
lacks a poly(A) tail. Importantly, SINV RNAs become the most
abundant RNA species, after rRNA, at 18 hpi (Figures 3G and
S3G). The emergence of such abundant RNA substrates likely in-
duces cellular RBPs to exchange the ‘‘declining’’ cellular mRNAs
for ‘‘emerging’’ viral RNAs, driving the remodeling of the
RBPome. Alternatively, ‘‘dormant’’ RBPs could be ‘‘awakened’’
by the recognition of signatures within the viral RNA, analogous
to known antiviral RBPs (Vladimer et al., 2014). We thus hypoth-
esized that RBPs displaying enhanced binding should co-
localize with viral RNA.
SINV RNA and capsid accumulate in cytoplasmic foci that
correspond to the viral factories (Figures S1D, 4B, and S4A).
To test whether stimulated RBPs relocate to these foci, we
generated 26 tetracycline-inducible cell lines expressing host
RBPs fused to EGFP. These included 16 lines expressing stimu-
lated RBPs and 8 expressing inhibited RBPs. The non-altered
RBP, MOV10, and unfused EGFP were used as controls. Strik-
ingly, 9 out of the 16 stimulated RBPs (56%) accumulated at viral
factories demarcated by SINV C (Figures 4C, 4D, and S4B). Five
additional stimulated RBPs (29%) showed diffuse localization in
cytoplasm but were also present at the capsid-containing
foci (Figure S4B). In situ hybridization analysis confirmed that
SINV RNA co-localized with a representative stimulated RBP,
GEMIN5, supporting the potential interplay between stimulated
RBPs and viral RNA (Figure S4C). Among the stimulated RBPs,
only NGDN, HNRNPA1 and themitochondrial translation elonga-
tion factor TUFM (3 out of 16; 17%) were absent in the viral fac-
tories, which suggests that their function is restricted to host
RNAs. HNRNPA1 was shown to bind SINV RNA (LaPointe
et al., 2018; Lin et al., 2009), while in our analysis, it strictly dis-
plays nuclear localization (Figure S4B). We cannot rule out that
a small pool of HNRNPA1 is present in the viral factories at unde-
tectable levels or, alternatively, that the EGFP tag is affecting
HNRNPA1 localization.
In contrast to stimulated RBPs, only one (out of 8; 12.5%) in-
hibited RBP was enriched in the viral factories (Figures 4D and(C) Localization by immunofluorescence of the EGFP-fused RBPs and SINV C. G
(white line) are plotted in (B) and (C).
(D) Summary of the observed localization of the 26 proteins tested in (C) and Fig
Scale bars represent 10 mm. AFU, arbitrary fluorescence units.
See also Figure S4.S4B). This protein, called UPF1, is a helicase involved in the
nonsense-mediated decay pathway and is known to inhibit
infection of alphaviruses (Balistreri et al., 2014). Conversely, 5
out of 8 (62.5%) virus-inhibited RBPs are nuclear and remained
nuclear after infection (Figures 4C, 4D, and S4B). These results
indicate that, with exceptions, inhibited RBPs do not redistribute
to the viral factories.
The Exonuclease XRN1 Is Essential for SINV Infection
The loss of cellular mRNAs is likely contributing to the remod-
eling of the RBPome by diminishing substrate availability. How-
ever, it is unclear how this phenomenon is triggered and
whether it benefits or hampers viral infection. Changes in
RNA levels can globally be a consequence of reduced tran-
scription and/or increased RNA degradation. To explore which
of these pathways contribute the most to RNA loss in SINV-in-
fected cells, we compared the fold change of each mRNA in
our dataset to the rate of synthesis, processing, and degrada-
tion of each individual transcript (Mukherjee et al., 2017). Tran-
scription could explain most of the differences at 4 hpi,
whereas RNA degradation accounted for more than 50% of
the explained variance at 18 hpi (Figures 5A and S5A). We
reasoned that this phenomenon can be a combined effect of
the activation of the 50 to 30 RNA degradation machinery, as
the exonuclease XRN1 and its interactor, PATL1, are stimulated
at 18 hpi (Table S1), and a reduced transcriptional activity
(Gorchakov et al., 2005).
XRN1 is broadly considered as an antiviral factor that erases
viral RNA (Molleston and Cherry, 2017). RNA pseudoknots pre-
sent in several viral RNAs are able to stall XRN1, leading to the
production of sgRNAs (Chapman et al., 2014; Pijlman et al.,
2008). In dengue virus (DENV), XRN1-derived sgRNAs can
benefit infection by interfering with the antiviral response (Mano-
karan et al., 2015).
In SINV-infected cells, XRN1 and MOV10 foci (corresponding
to P-bodies) are juxtaposed to the viral replication factories, sug-
gesting that the exonuclease could attack viral RNA (Figures 4C,
S4C, and 5B). To our surprise, XRN1 knockout (KO) cells were
refractory to SINV infection, while partial KO led to an intermedi-
ate phenotype (Figure 5C). These results suggest that XRN1 ac-
tivity is instead essential for SINV infection. XRN1 KO cells did
not exhibit any defect in cell morphology, proliferation rate, or
viability, and they supported efficiently the replication of HIV-1
(Figures 5D and S5C–S5F). These results indicate that XRN1
KO lines are not metabolically deficient or subjected to a heavy
stress incompatible with virus infection.
To determine if XRN1 activity involves the generation of
RNA degradation products, we analyzed our RNA-seq data.
However, we did not found any increase in read coverage
compatible with XRN1-derived degradation products, suggest-
ing that XRN1 role in SINV infection differs from that described
for DENV.reen and red fluorescence intensity profiles in a representative 5-mm section
ure S4B.
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Figure 5. The Exonuclease XRN1 in Cells Infected with SINV
(A) Contribution of transcription, processing, and degradation to the transcriptomic changes induced by SINV. We compared our RNA-seq data to available data
estimating these parameters (Mukherjee et al., 2017). ANOVA was used to predict the contribution of each RNA biological process to the variance in RNA levels.
(B) Immunolocalization of XRN1 and SINV C. Green and red fluorescence profiles for regions of interest (ROI) are displayed.
(C) Top: mCherry fluorescence in XRN1 KO and control cells infected with SINV-mCherry measured every 15 min in a plate reader with atmospheric control
(5% CO2 and 37C). RFU, relative fluorescence units. Western blot of XRN1 and SINV C (bottom).
(D) Infection fitness of HIV-1Nef-mCherry and HIV-1Gag-mCherry pseudotyped viruses in XRN1 KO cells. mCherry expression was measured as in (C).
mCherry fluorescence is represented as mean ± SD of three independent infections in each of the three biological replicates (n = 9). ***p < 0.001; **p < 0.01;
*p < 0.05.
See also Figure S5.RBPome Responses Are Biologically Important
To determine to a broader extent whether RBP responses are
functionally important, we sought to study the impact of altered
RBPs on virus infection. The ligase RTCB, together with DDX1,
FAM98A, and other RBPs, forms the tRNA ligase complex
(TRLC) (Popow et al., 2011). RTCB and DDX1 were stimulated
by SINV (Table S1), and these and FAM98A accumulated in
the viral factories (Figures 4C and S4B). TRLC mediates the un-204 Molecular Cell 74, 196–211, April 4, 2019usual ligation of 30-phosphate or 20,30-cyclic phosphate to a
50-hydroxyl and these molecule ends are generated by a limited
repertoire of cellular endonucleases, which include the endo-
plasmic reticulum resident protein IRE1a (Popow et al., 2011).
SINV has been proposed to cause unfolded protein response
(Rathore et al., 2013), which is compatible with the activation
of IRE1a and TRLC in infected cells (Jurkin et al., 2014). Notably,
inhibition of IRE1awith 4m8C strongly reduced viral fitness in low,
non-cytotoxic concentrations (Figures 6A and S6A), suggesting
that IRE1a and TRLC are positively contributing to SINV
infection.
PPIA (also cyclophilin A) has also been classified as an RBP by
RIC studies (Hentze et al., 2018). It switches proline conforma-
tion-modulating protein activity, which plays a crucial role in hep-
atitis C virus infection (Rupp and Bartenschlager, 2014). PPIA is
also important for the infection of other viruses, such as HIV-1
(Li et al., 2007). PPIA RNA-binding activity is stimulated by
SINV infection and is recruited to the viral factories (Figures 2E
and S4B). Interestingly, SINV-mCherry infection is delayed by
PPIA loss of function (KO and inhibition; Figures 6B, S6A, and
S6B). Overexpression had no effect in SINV-mCherry fitness
(Figure 6B, bottom).
The heat shock chaperone HSP90AB1 is stimulated by SINV
(Table S1). HSP90AB1 has been classified as an RBP by RIC
(Hentze et al., 2018), and its RBD has been located in a discrete
region at its C-terminal domain (Figure S6C) (Castello et al.,
2016). Chaperones from the HSP90 family are important in the
remodeling of RNPs and are linked to virus infection (Geller
et al., 2012; Iwasaki et al., 2010). Notably, SINV-mCherry infec-
tion was significantly delayed in HSP90AB1 KO cells, even
though four homologs of this protein exist (Figures 6C and
S6B). Moreover, the pro-viral activity of HSP90AB1 was
confirmed by treatment with specific inhibitors (Figures 6C and
S6A). Again, overexpression had no effect in SINV-mCherry
fitness (Figure 6C). The implication of PPIA and HSP90 in the
biological cycle of a variety of unrelated viruses highlights these
proteins as master regulators of infection (Garcia-Moreno
et al., 2018).
PA2G4 RNA-binding activity was also enhanced by SINV
(Table S1). It associates with ribosomes (Table S2) (Simsek
et al., 2017) and regulates the cap-independent translation
of foot-and-mouth disease virus (FMDV) RNA (Monie et al.,
2007). Treatment with its specific inhibitor WS6 hampered
SINV-mCherry fitness (Figures 6D and S6A), suggesting that
this protein promotes SINV infection. Overexpression did not
cause any effect, as with previous examples (Figure 6D).
The possibility that PA2G4 contributes to the non-canonical,
cap-dependent translation of SINV RNAs should be further
investigated.
SRPK1 is a kinase that phosphorylates the RS repeats pre-
sent in SR proteins, which are involved in alternative splicing
regulation, RNA export, and stability (Howard and Sanford,
2015). SINV infection stimulates SRPK1 RNA-binding activity
(Table S1) and causes its relocation to viral replication factories
(Figure 4C). Inhibition of SRPK1 hampers SINV and HIV-1
infection (Fukuhara et al., 2006), and we show here that
overexpression of SRPK1 enhances SINV fitness (Figure 6E).
This suggests that SRPK1 positively contributes to SINV
infection. Future work should determine if SRPK1 kinase
activity is involved in infection, and if so, which proteins it
phosphorylates.
We tested the effects of overexpression of nine additional
stimulated or inhibited RBPs fused to EGFP (Figures S6D and
S6E). Phenotypes in viral fitness ranged from nonexistent
(ALDOA, XRCC6, RPS10, MOV10, NGDN, and CSTF2) to mild
(RPS27, NONO, and DKC1). The lack of phenotypic effects inoverexpression experiments does not rule out that the protein
actually participates in SINV infection (see above). Nevertheless,
RBPs whose overexpression affects infection fitness have po-
tential as regulatory proteins.
The family of tripartite-motif-containing (TRIM) proteins
comprises more than 75 members endowed with E3 ubiquitin
ligase activity, and few of them have been classified as RBPs
by RIC (Hentze et al., 2018). Notably, SINV infection enhanced
TRIM25 and TRIM56 interaction with RNA (Table S1), corre-
lating with their redistribution to viral replication factories (Fig-
ure 4C). TRIM25 was proposed to interact with DENV RNA
(Manokaran et al., 2015); however, this analysis employed
native immunoprecipitation (IP) that cannot distinguish be-
tween direct and indirect protein-RNA interactions. To test if
TRIM25 interacts directly with SINV RNA, we immunoprecipi-
tated under stringent conditions TRIM25-EGFP from SINV-
infected cells irradiated with UV light. Co-precipitated RNA
was analyzed by RT-PCR using specific primers against
SINV RNA. A band with the expected size was detected in
TRIM25-EGFP IPs, but not in the negative controls (Figure 7A),
confirming that TRIM25 interacts with SINV RNA directly.
TRIM25 interaction with RNA enhances its E3 ubiquitin ligase
activity (Choudhury et al., 2017). TRIM25-EGFP overexpres-
sion inhibited SINV-mCherry infection (Figure 7B), which
agrees with its ability to activate the key antiviral factors
RIG-I and ZC3HAV1 through ubiquitination (Gack et al.,
2007; Li et al., 2017). It is known that TRIM56 binds double-
stranded DNA. However, it enhances the antiviral response
in cells infected with both DNA and RNA viruses (Seo et al.,
2018; Tsuchida et al., 2010). cRIC thus complements these
results, revealing that TRIM56 interacts directly with RNA
(Table S1). As with TRIM25, overexpression of TRIM56-
EGFP reduced SINV fitness (Figure 7B), confirming its capac-
ity to restrict the infection of the RNA virus, SINV.
Importantly, 160 out of the 247 altered RBPs lack previous
connections to virus infection (Garcia-Moreno et al., 2018).
Hence, our dataset likely contains numerous pro- and antiviral
RBPs yet to be uncovered.
GEMIN5 Binds to the 50 UTR of SINV RNAs and Regulates
Viral Protein Expression
GEMIN5 is a member of the survival motor neuron (SMN) com-
plex, which mediates the assembly of the small nuclear RNPs
(snRNPs) (Gubitz et al., 2002). It is strongly stimulated by SINV
infection and redistributed to the viral factories co-localizing
with SINV RNA (Figures 2E, 4C, and S4C). To our surprise,
none of the known molecular partners of GEMIN5 (i.e., GEMIN
and SMN proteins) were stimulated by SINV (Table S1), implying
a GEMIN5-specific response that agrees with the existence of a
free pool of GEMIN5 (Battle et al., 2007). In SINV-infected cells,
overexpression of GEMIN5-EGFP caused amoderate but signif-
icant delay of mCherry production and strongly inhibited capsid
synthesis (Figure 7B). These results align well with the described
role of GEMIN5 in translational control (Francisco-Velilla et al.,
2018; Pin˜eiro et al., 2015).
Protein-protein interaction analysis of GEMIN5-EGFP re-
vealed that, in our experimental settings, it interacts with the
ribosome, especially with the 60S subunit (Figure 7C, pinkMolecular Cell 74, 196–211, April 4, 2019 205
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Figure 6. Impact of Stimulated RBPs in SINV Infection
(A) Expression of mCherry in HEK293 cells infected with SINV-mCherry and treated or not with the IRE1a inhibitor 4m8C. Red fluorescence was measured as in
Figure 5C.
(B) As in (A) but with PPIA KO cells (top), the PPIA inhibitor cyclosporine A (CysA) (middle), and cells overexpressing PPIA-EGFP (bottom). KO and overexpression
of PPIA and SINV C accumulation (18 hpi) were assessed by western blotting.
(C) mCherry fluorescence in HSP90AB1 KO cells (top), cells treated with ganetespib or geldamycin (middle panels), or cells overexpressing HSP90AB1-EGFP
(bottom) and infected with SINV-mCherry. KO and overexpression of HSP90AB1 and SINV C accumulation (18 hpi) were assessed by western blotting.
(D) As in (A) but using the PA2G4 inhibitor WS6 (top) and cells overexpressing PA2G4-eGFP (midde). Right: western blots against SINV C at 18 hpi.
(E) As in (A) but with cells overexpressing SRPK1 (top). Overexpression of SRPK1 was assessed by western blotting. Bottom: western blots of SINV C in these
cells at 18 hpi.
mCherry fluorescence is shown as the mean ± SD of three independent infections in each of the three biological replicates (n = 9). ***p < 0.001; **p < 0.01;
*p < 0.05. SINV-mChe, SINV-mCherry; n.s., non-significant.
See also Figure S6.
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dots, left; Figures S7C and S7D; Table S5). This interaction is
sustained in SINV-infected cells (Figure 7C, pink dots, middle
and right). These results are in agreement with previous studies
showing that GEMIN5 impacts protein synthesis at the transla-
tion elongation step through its direct interaction with the 60S ri-
bosomal subunit and, in particular, with RPL3 and RPL4, which
are also enriched in our IPs (Table S5) (Francisco-Velilla et al.,
2016). We noticed that GEMIN5 is by far the most enriched
protein in our IPs and that its Intensity Based Absolute Quantifi-
cation (iBAQ) score is significantly higher than that of EGFP, sug-
gesting that GEMIN5-EGFP interacts with the endogenous
GEMIN5, likely forming oligomers, as previously described (Xu
et al., 2016). Moreover, our data showed that GEMIN5 interacts
with various viral proteins, chiefly with NSP1, NSP2, NSP3 and
SINV C (Figure 7C, middle). The implications of these interac-
tions in the modulation of GEMIN5 function deserve future
considerations.
GEMIN5 is cleaved by the L protease of FMDV, and resulting
C-terminal moiety enhances internal ribosome entry site (IRES)-
driven translation (Pin˜eiro et al., 2013). However, GEMIN5 is not
cleaved in SINV-infected cells (Figure 3E), and SINV RNAs lack
an IRES and are capped (Carrasco et al., 2018). To test
whether GEMIN5 binds SINV RNA, we performed an IP and
RT-PCR analysis as outlined above. A PCR product was ampli-
fied in GEMIN5-EGFP eluates (Figure 7A), which agrees with
the striking co-localization of SINV RNA and GEMIN5 (Fig-
ure S4C). To get insights into how GEMIN5 recognizes SINV
RNAs, we employed single-nucleotide-resolution crosslinking
and immunoprecipitation followed by sequencing (iCLIP) (Ko¨nig
et al., 2010). Interestingly, the footprints with highest coverage
mapped to the 50 ends of the gRNA and sgRNA (Figures 7D and
S7E–S7G). These reads often presented an additional guano-
sine at the 50 end (Figure S7H), likely reflecting binding to the
cap structure. These results support previous data showing
that GEMIN5 is captured in cap-Sepharose beads (Bradrick
and Gromeier, 2009). Additional peaks overlap with the down-
stream loop (DLP), which is a hairpin structure that stimulates
the translation of the sgRNA (Frolov and Schlesinger, 1996).
Interaction with the cap, 50 UTR, and DLP of viral RNAs aligns
well with the proposed role as translational regulator and the
observed inhibition of capsid expression. Our data support
the model in which GEMIN5 recognizes the 50 end of theFigure 7. Effects of RBPs with Antiviral Potential in SINV Infection
(A) UV crosslinking and immunoprecipitation of TRIM25-EGFP, GEMIN5-EGFP, X
presence of SINV RNA in eluates and inputs was detected by RT-PCR using spe
(B) Relative mCherry fluorescence produced in cells overexpressing TRIM25-EGF
with SINV-mCherry (measured as in Figure 5C). mCherry expression is represe
biological replicates (n = 9). Overexpression was assessed by western blotting. Bo
of C relative to control cells. ***p < 0.001; **p < 0.01.
(C) Volcano plots comparing the intensity of proteins in GEMIN5-EGFP versus u
resents a protein. Dark green dots are proteins enriched with p < 0.01, blue dots a
Pink dots represent ribosomal proteins. Right: a volcano plot comparing the inte
(D) iCLIP analysis of GEMIN5-binding sites on SINV RNA. Top: coverage pileup of
sliding mean of five replicates after GFP background subtraction. Each positio
annotation. Bottom: the top track shows iCLIP coverage but as a heatmap represe
into five groups according to strength of binding. The bottom heatmap shows the
independently for each replicate.
See also Figure S7 and Table S5.
208 Molecular Cell 74, 196–211, April 4, 2019gRNA and sgRNA and prevents their translation by interfering
with ribosomal function.
Outlook
We show here that SINV infection induces changes in the active
RBPome that affects both well-established and unconventional
RBPs. Mechanistically, the RBPome rearrangement can be ex-
plained by the loss of cellular RNA and the emergence of the
highly abundant viral RNA. Supporting this conclusion, we
observed that most of the RBPs with enhanced activity
accumulate in the viral factories together with the viral RNA.
However, this RNA-driven remodeling of the RBPome is
not incompatible with complementary ‘‘fine-tuning’’ regulatory
mechanisms affecting RBPs on an individual basis. For example,
it is known that virus infection triggers signaling pathways
involving kinases (Figure 1D), E3 ubiquitin ligases, prolyl cis/trans
isomerases, and chaperones (Carrasco et al., 2018; Gack et al.,
2007; Li et al., 2017). Here, we show that these protein families
are represented among the stimulated RBPs, including SRPK1,
TRIM25, TRIM56, PPIA, and HSP90AB1. Hence, it is plausible
that post-translational control also contributes to RBP regulation
in SINV-infected cells. Moreover, interactions with viral proteins
can regulate RBP function (Fros et al., 2012). We show that
GEMIN5 interacts with several viral proteins, suggesting that
this regulatory mechanism may apply to altered RBPs more
broadly (Figure 7C).
Importantly, changes in the RBPome are biologically impor-
tant, as perturbation of the altered RBPs strongly affects
SINV infection. Therefore, every protein reported here to
respond to SINV infection has potential as anti- or pro-viral fac-
tor, highlighting cellular RBPs as promising targets for antiviral
therapies.
Some of the outstanding questions derived from this work
include whether the distinct composition of ribosomes in in-
fected cells affects their translational properties, why the lack
of the exonuclease XRN1 makes the cells refractory to SINV,
what triggers the degradation of host RNA, and why the
transcripts induced by the antiviral response are resistant to
degradation. Moreover, GEMIN5 emerges as a highly respon-
sive RBP that impairs SINV infection. The exact mechanisms
underpinning GEMIN5 effects in translation require further
investigation.RCC6-EGFP, or unfused EGFP in cells infected or not with SINV for 18 h. The
cific primers against SINV RNAs.
P (top left), TRIM56-eGFP (top middle), GEMIN5-eGFP (top right), and infected
nted as the mean ± SD of three independent infections in each of the three
ttom: western blots of SINV C at 18 hpi, indicating below the average inhibition
nfused EGFP IPs in uninfected (left) and infected cells (middle); every dot rep-
re those enriched with p < 0.1, and gray dots represent nonenriched proteins.
nsity of proteins in GEMIN5 IPs in infected versus uninfected cells.
50 first base of unique molecules mapping to the SINV genome, shown as 20-nt
n is given relative to total SINV count (RPM). Middle: key features of SINV
ntation. The middle heatmap shows GEMIN5 binding sites along SINV divided
number of replicates supporting each binding site when binding sites are called
Finally, cRIC has been applied here to cells infected with SINV.
However, it can now be extended to other viruses or physiolog-
ical cues to improve our understanding of RBP regulation and its
biological importance.
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4.4.5.5-D4-L-Lysine SILANTES GmbH Cat# 211104113
Cyclosporin A (CAS N 59865-13-3) Insight Biotechnology Ltd Cat# sc-3503
Ganetespib (CAS N 888216-25-9) Cambridge Bioscience Ltd Cat# 19432
Geldanamycin (CAS N 30562-34-6) Cambridge Bioscience Ltd Cat# SM55-2
IRE1 Inhibitor III, 4m8C (CAS N 14003-96-4) Merck Chemicals Ltd Cat# 412512
WS6 (CAS N 1421227-53-3) Cambridge Bioscience Ltd Cat# 17672
Critical Commercial Assays
CellTiter 96 AQueous One Solution Cell Proliferation
Assay (MTS)
Promega Cat# G3580
Deposited Data
Proteome Xchange via PRIDE Deutsch et al., 2017 PXD009789
RNA-seq via GEO GEO: GSE125182
iCLIP via GEO GEO: GSE125182
Experimental Models: Cell Lines
HEK293 ECACC Cat# 85120602 RRID:CVCL_0045
HeLa Kyoto ATCC Cat# CCL-2 RRID:CVCL_1922
Flp-In-T-Rex-293 Thermo Fisher Scientific Cat#R78007 RRID:CVCL_U427
Flp-In-T-Rex-HeLa Laboratory of M. Gromeier N/A
BHK-21 ECACC Cat# 85011433 RRID:CVCL_1915
Oligonucleotides
CRISPR guide RNA targeting XRN1: AAUGCGAAACA
ACACCUCCGUUUUAGAGCUAUGCUGUUUUG
Sigma-Aldrich Co Ltd HS0000076809
TRIM25 left sgRNA: CCACGTTGCACAGCACCGTGTTC This paper N/A
TRIM25 right sgRNA: CTGCGGTCGCGCCTGGTAGACGG This paper N/A
Primers for cloning, see Table S6 This paper N/A
Primers for RT-PCR, see Table S6 This paper N/A
Recombinant DNA
CRISPR/CAS9 plasmid: PX459 HSP90AB1_out_of_
frame_67
This paper N/A
guide sequence: CTCACACCTTGACTGCCAAG
CRISPR/CAS9 plasmid: PX459 PPIA_out_of_frame_57 This paper N/A
guide sequence: GCCCGACCTCAAAGGAGACG
pOG44 ThermoFisher Scientific Cat# V600520
pcDNA5/FRT/TO ThermoFisher Scientific Cat# V652020
pNL4-3.Luc.R-E- NIBSC – Centre for AIDS
Reagents
Cat# 2128
pNL4-3 NIBSC – Centre for AIDS
Reagents
Cat# 2006
pHEF-VSVG NIH AIDS Reagent Program Cat# 4693
Software and Algorithms
REST Pfaffl, 2001
STRING Szklarczyk et al., 2017 https://string-db.org/
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STAR Dobin et al., 2013 https://github.com/alexdobin/STAR
Subread FeatureCount Liao et al., 2013 http://bioinf.wehi.edu.au/subread-package/
SAMtools Li et al., 2009 http://samtools.sourceforge.net/
RBDmap Castello et al., 2016 https://www-huber.embl.de/users/
befische/RBDmap/
DSseq2 Love et al., 2014 https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
Pheatmap Kolde, 2015 https://cran.r-project.org/web/
packages/pheatmap/index.html
iCount https://github.com/tomazc/iCount
biomaRt Durinck et al., 2009 https://bioconductor.org/packages/
release/bioc/html/biomaRt.html
ggplot2 Wickham, 2009 https://cran.r-project.org/web/
packages/ggplot2/index.html
MaxQuant (version 1.5.0.35) Cox and Mann, 2008 https://www.maxquant.org/
Perseus Tyanova et al., 2016 http://maxquant.net/perseus/
hom.Hs.inp.db Carlson and Pages, 2015 http://bioconductor.org/packages/
release/data/annotation/html/
hom.Hs.inp.db.html
mRNAinteractomeHeLa Castello et al., 2012 http://www.hentze.embl.de/
public/RBDmap/
Semiquantitative test for protein differential analysis This paper N/A
limma (for moderated t test) Smyth, 2004 https://bioconductor.org/packages/
release/bioc/html/limma.html
ANOVA https://www.itl.nist.gov/div898/
handbook/eda/section3/eda355.htmCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alfredo
Castello (alfredo.castellopalomares@bioch.ox.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
We used here human embryo kidney 293 cells (HEK293, ECACC #85120602), HeLa (ATCC cat. no. CCL-2) and baby hamster kidney
cells (BHK-21, clone 13, ECACC #85011433); HEK293 Flp-In TREx are commercially available (Thermo Fisher Scientific, #R78007),
while HeLa Flp-In TREx are a generous gift from Dr. Matthias Gromeier (Duke University Medical Center, Durham, NC, USA). All cells
were cultured in DMEM with 10% FBS and 1x penicillin/streptomycin (Sigma Aldrich, #P4458) at 37C with 5% CO2. The media of
Flp-In TREx (Tet-on) cells was supplemented with 15 mg/ml Blasticidin S and 100 mg/ml Zeocin. To generate RBP-eGFP-expressing
cell lines, cells were transfected with pOG44 and the corresponding pcDNA5-FTR-TO plasmid (Table S6) using X-tremeGENE 9 DNA
transfection reagent following manufacturer’s recommendations (Sigma-Aldrich, #6365787001). For the selection of inducible cell
lines, Zeocin was replaced by 150 mg/ml Hygromycin B as indicated in the manufacturer’s manual (Thermo Fisher Scientific). Protein
induction was achieved by supplementation of the medium with 1 mg/ml doxycycline. To generate KO cells, we transfected HEK293
using TRANSIT-CRISPR (Sigma-Aldrich) with SygRNAs assembled with Cas9 (Sigma-Aldrich, #CAS9PROT-50UG) and tracrRNA
(Sigma-Aldrich, #TRACRRNA05N-5NMOL), followed by cell serial dilution and selection of KO cell clones. Alternatively, we gener-
ated px459 derived plasmids including sequences targeting the genes of interest (pX459 was a gift from Feng Zhang; Addgene
plasmid #62988). These plasmids were transiently transfected into HEK293 cells using X-tremeGENE 9. Cells expressing the
construct were selected with 1 mg/ml puromycine for 96 h, followed by cell serial dilution to obtain individual clones. To generate
TRIM25 KO cells, HEK293 were transfected with 200 ng GeneArt CRISPR nucleasemRNA (Thermo Fisher Scientific, #A29378) along
with 50 ng of two distinct, in vitro transcribed sgRNAs targeting sequences in exon 1 of the TRIM25 gene. Single cells were seeded,
grown and checked for KO by western blotting.e3 Molecular Cell 74, 196–211.e1–e11, April 4, 2019
Cell culture in SILAC media
Cells were grown in SILAC DMEM media (Thermo Scientific, #10107883) containing 10% dialysed FBS (Silantes GmbH,
#281000900) and isotopic labeled arginine and lysine (Silantes GmbH amino acids: L-Arginine 13C,15N labeled #201604102; L-Argi-
nine 13C labeled #201204102; L-Lysine 13C,15N labeled #211604102; 4.4.5.5.-D4-L-Lysine #211104113). Prior to experiments, we
confirmed bymass spectrometry that the incorporation of isotopic labeled amino acids was superior to 98%using whole cell lysates.
Viruses
We used the SINV clone pT7-SVwt (Sanz and Carrasco, 2001) to generate the SINV suspension. The plasmid pT7-SVmCherry was
generated by inserting mCherry after the duplicated subgenomic promoter in pT7-SVwt. To obtain SINV and SINV-mCherry viruses,
pT7-SVwt and pT7-SVmCherry plasmids were first linearized with XhoI and used as a template for in vitro RNA transcription with
HiScribe T7 ARCA mRNA kit (New England Biolabs, #E2065S). Transcribed genomic RNA was transfected into BHK-21 using Lip-
ofectamine 2000 reagent (Invitrogen, #11668027). Viruses were collected from the supernatant 24 h later and cleared by centrifuga-
tion at 2000 rpm for 3 min followed by filtration with 0.45mm PVDF syringe filter units (Merck, #SLHV033RS). Cleared supernatants
were titrated by plaque assay using BHK-21 cells.
Pseudotyped HIV-1Nef-mCherry and HIV-1Gag-mCherry were produced as follows. For HIV-1Nef-mCherry, a sequence encoding the end
of env followed by a linker, mCherry, T2A self-cleaving peptide and the beginning of Nef protein was synthesized using the GeneArt
Gene synthesis service (Thermo Fisher Scientific), and cloned between the BamHI and XhoI restriction sites of pNL4-3.Luc.R-E-
plasmid (NIBSC – Centre for AIDS Reagents, #2128), which is defective for Vpr and Env. For HIV-1Gag-mCherry, a PSPXI restriction
site flanked by flexible linker was introduced into gag of the pNL4-3 plasmid (NIBSC – Centre for AIDS Reagents, #2006) by over-
lapping PCR (primers in Table S6) as in (M€uller et al., 2004). mCherry sequence was amplified by PCR flanked by PspXI restriction
sites and cloned into pNL4-3 using the newly generated PspXI site. Finally, the fragment between SpeI and BamHI was replaced by
that of pNL4-3.Luc.R-E-. Pseudotyped viral particles were produced by co-transfecting HEK293T cells (kindly provided by Prof. Jan
Rehwinkel, University of Oxford, UK) with pNL4-3.R-E-Nef-mCherry or pNL4-3.R-E-Gag-mCherry plus pHEF-VSVG (NIH AIDS Reagent
Program, #4693), which encodes for the glycoprotein of vesicular stomatitis virus (VSV).
METHOD DETAILS
RNA interactome capture
Comparative RNA interactome capture (cRIC) was performed based on the previously described protocol (Castello et al., 2012; Cas-
tello et al., 2013) with the following alterations: HEK293 cells, previously grown in media with isotopic labeled amino acids, were
seeded in three sets of 3x15 cm dishes at 80% confluence, each set with a different SILAC label. One set of dishes remained unin-
fected and two sets were infected with SINV at a multiplicity of infection (MOI) of 10. One of these infected cell sets was incubated for
4 h and the other for 18 h. To correct for isotope-dependent effects, we permutated the SILAC labels between the three conditions in
the three biological replicates. After incubation, cells were irradiated with 150 mJ/cm2 of UV light at 254 nm, and lysed with 3 mL of
lysis buffer (20mMTris-HCl pH 7.5, 500mMLiCl, 0.5%LiDSwt/vol, 1mMEDTA, 0.1% IGEPAL (NP-40) and 5mMDTT). Lysateswere
homogenized by passing the lysate at high speed through a 5 mL syringe with a 27G needle, repeating this process until the lysate
was fully homogeneous. 400 ml of lysate were taken for total proteome and transcriptome analysis (Figure 3; Tables S3 and S4). Pro-
tein content was measured using a kit compatible with ionic detergents (Thermo Fisher, Pierce 660nm Protein Assay Kit #22662 with
IDC reagent #22663) and equal amounts of each of the three lysates weremixed. The final volumewas adjusted to 9mL and 1.5mL of
pre-equilibrated oligo(dT)25 magnetic beads (New England Biolabs, #S1419S) were added and incubated for 1 h at 4
C with gentle
rotation. Beads were collected in the magnet and the lysate was transferred to a new tube and stored at 4C. Beads were washed
once with 10 mL of lysis buffer, incubating for 5 min at 4C with gentle rotation, followed by two washes with 10 mL of buffer 1
(20 mM Tris-HCl pH 7.5, 500 mM LiCl, 0.1% LiDS wt/vol, 1 mM EDTA, 0.1% IGEPAL and 5 mM DTT) for 5 min at 4C with gentle
rotation and two washes with buffer 2 (20 mM Tris-HCl pH 7.5, 500 mM LiCl, 1 mM EDTA, 0.01% IGEPAL and 5 mM DTT). Beads
were then washed twice with 10 mL of buffer 3 (20 mM Tris-HCl pH 7.5, 200 mM LiCl, 1 mM EDTA and 5 mM DTT) at room temper-
ature. Beads were resuspended in 900 ml of elution buffer and incubated for 3 min at 55C with agitation. Eluates were stored
at 80C and beads were recycled as indicated in the manufacturer’s manual, and re-used for two additional capture rounds. For
RIC experiments followed by western blot analysis, we used the small scale RIC settings described in (Castello et al., 2013).
Conventional protein analyses
Samples were resolved on SDS-PAGE and analyzed by i) western blotting using specific antibodies, the Li-Cor Odyssey system for
visualization and the Image Studio Lite software (Li-Cor) for quantification, ii) Coomassie blue staining with the InstantBlue Protein
Stain reagent (Expedeon, #ISB1L) or iii) silver staining using SilverQuest kit (Invitrogen, #LC6070). Data shown in the manuscript
are representative gels from at least three independent replicates. Details on antibodies can be found in the key resource table.
Radioactive labeling of newly synthesized proteins was performed by replacing the growth media for 1 h with DMEM lacking methi-
onine and cysteine and supplemented with Easytag EXPRESS35S Protein Labeling Mix [35S]Met-Cys (Perkin Elmer,
#NEG772002MC). Samples were then analyzed by SDS-polyacrylamide gels (15%) followed by autoradiography.Molecular Cell 74, 196–211.e1–e11, April 4, 2019 e4
Reverse-transcription and quantitative PCR
Total RNAwas isolated using TRIzol (Invitrogen, #15596026). Reverse transcription was performed using Superscript III reverse tran-
scriptase (Invitrogen, #18080044) with random hexamers priming (Invitrogen, #N8080127), following manufacturer’s instructions.
RT-qPCR analysis was performed with 2x qPCR SyGreen Mix Lo-ROX (PCRBiosystems, #PB20.11-01) and gene specific primers
(Table S6) in a BioRad CFX96 Real-Time system, and analyzed with REST software (Pfaffl, 2001).
Plasmids and recombinant DNA procedures
Plasmids for generation of inducible cell lines were created by conventional cloning methods. Inserts were generally amplified from
HEK293 cDNA or template plasmids using specific primers (Table S6). Inserts were cloned into the pcDNA5/FRT/TO with eGFP pre-
ceded or followed by a flexible linker encoding for GGSGGSGG (glycine and serine repeats) to facilitate the folding of the RBP of
interest independently from the eGFP. For CRISPR/Cas9 expression plasmids, annealed oligos were inserted into the BbsI site
of px459.
mCherry-based viral fitness assay
5x104 cells were seeded on each well of a 96-well microplate with flat mClear bottom (Greiner Bio-One, #655986) in DMEM lacking
phenol-red and supplemented with 5% FBS and 1 mM sodium pyruvate. Cells (control, knock-out and Tet-on) were infected with
SINV-mCherry at 0.1 MOI in complete DMEM (lacking phenol-red) with 2.5% FBS. Cells were incubated at 37C and 5% CO2 in a
CLARIOstar fluorescence plate reader (BMG Labtech) for 24 h; eGFP and/or mCherry signal was monitored by measuring fluores-
cence (eGFP: excitation 470 nm, emission 515 nm; mCherry: excitation 570 nm, emission 620 nm) every 15 min. To monitor the shut
off of protein synthesis with this method (Figure S1B), Tet-on HEK293 eGFP-control cells were induced with 1 mg/ml doxycycline for
4 h and then infected as indicated above. In experiments with HIV-1 mCherry replicons, 5x104 cells were seeded on each well of
a 96-well plate in clear DMEM supplemented with 2.5% FBS and 1 mM sodium pyruvate, and infected with pseudotyped
HIV-1Nef-mCherry or HIV-1Gag-mCherry. mCherry signal wasmonitored for 72 h in a fluorescence plate reader as indicated above. In over-
expression experiments, Tet-on HEK293 cells expressing RBP-eGFP fusion proteins were either induced with 1 mg/ml doxycycline
for 16 h or mock-induced and then infected with SINV-mCherry. In inhibitor assays, HEK293 cells were infected with SINV-mCherry
as above and inhibitors or vehicle (DMSO) were added at 1 hpi at the concentrations indicated in the figures. Statistical significance of
the difference in mCherry expression at 18 and 24 hpi was determined by t test (n = 9).
Drugs and cell viability assay
The following chemical inhibitors were used in this work: cyclosporin A (Insight Biotechnology Ltd, #sc-3503), Ganetespib (Cam-
bridge Bioscience Ltd, #19432), Geldanamycin (Cambridge Bioscience Ltd, #SM55-2), 4m8C (Merck Chemicals, #412512) and
WS6 (Cambridge Bioscience Ltd, #17672). To test cell viability at the concentrations used, 5x104 HEK293 cells were seeded on
each well of a 96-well microplate with flat, transparent bottom and incubated with DMEM (no phenol red) supplemented with 5%
FBS and 1 mM sodium pyruvate. 24 h later cells were treated with the compounds and incubated for another 24 h at 37C and
5%CO2. Cell viability was estimated by adding CellTiter 96 Aqueous One Solution (Promega, #G3580) andmeasuring 490 nm absor-
bance following themanufacturer’s recommendations. To evaluate cell viability and proliferation in knockout cells, 2.5x104 cells were
seeded per well of a 96-well plate and incubated in DMEM (no phenol red, 5%FBS, 1mM sodium pyruvate) at 37C and 5%CO2. Cell
viability was measured at the indicated times using CellTiter 96 Aqueous One Solution as described above. In parallel, the number of
cells was counted using the Countess II FL Automated Cell Counter (Thermo Fisher Scientific).
Protein-protein interactions analysis
4.2x106 HEK293 Tet-on cells expressing eGFP or GEMIN5-eGFP proteins were seeded on a 10 cm dish and incubated with DMEM
supplemented with 10% FBS and 1 mg/ml doxycycline. After 24 h, cells were infected with 10 MOI of SINV in DMEM lacking FBS and
incubated for 1 h, followed by media exchange (DMEM with 1% FBS). Cells were harvested at 18 hpi and lysed in 1 mL of Triton-X-
lysis buffer (10 mM Tris HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, 5 mM DTT and 0.1 mM AEBSF serine protease
inhibitor). For immunoprecipitation (IP), 40 ml GFP-Trap_A beads slurry (ChromoTek GmbH, #gta-20) were equilibrated in Triton-X-
lysis buffer and then added to 500 ml of whole-cell lysate. Mixture was diluted with 4.5 mL of Triton-X-lysis buffer, and mixed with
gentle rotation for 16 h at 4C. GFP-Trap beads were washed once with Triton-X-lysis buffer, collecting the beads by gentle centri-
fugation after each wash (1000 g for 5min at 4C). In the secondwash, the Triton-X-lysis buffer was supplemented with 1 ml/ml RNase
A (Sigma Aldrich, #4642) and beads were incubated for 5 min at 37Cwith gentle rotation. Beads were washed three additional times
with Triton-X-lysis buffer. Proteins were released from the GFP-Trap beads via pH elution by resuspension in 50 ml 0.2 M glycine pH
2.5 for 30 s followed by collection of the beads through a quick spin. The supernatant was transferred to a new tube and neutralised
with 5 ml of 1 M Tris base pH 10.4.
RBP-RNA interaction analysis: CLIP/RT-PCR
6.5x105 cells were seeded on each well of a 6-well plate and incubated in DMEMwithout phenol red and supplemented with 5% FBS
and 1 mg/ml doxycycline. After 24 h, cells were either mock-infected or infected with SINV at aMOI of 10. At 18 hpi, culture media was
removed and cells were irradiated with 150 mJ/cm2 of UV light at 254 nm. Cells were lysed in 400 ml of lysis buffer (100 mM KCl,e5 Molecular Cell 74, 196–211.e1–e11, April 4, 2019
5 mM MgCl2, 10 mM Tris pH 7.5, 1% IGEPAL, 1 mM DTT, 100 U/ml Ribolock RNase inhibitor [ThermoFisher Scientific, #EO0381],
0.1 mM AEBSF, 200 mM ribonucleoside vanydil complex). Lysates were diluted with 5x high-salt buffer (1.25 M NaCl,
100 mM Tris pH 7.5, 0.1% SDS) and H2O to reach 500 ml of 1x high-salt buffer. Lysates were then cleared by centrifugation
(5000 rpm for 3 min at 4C). Supernatants were transferred to a new tube and snap frozen in dry ice. An aliquot (50 ml) was taken
as ‘input’. Lysates were pre-cleared with 15 ml of pre-equilibrated control agarose beads (Pierce Control Agarose resin, Thermo
Fisher Scientific, #26150) by incubation under gentle rotation for 30 min at 4C followed by centrifugation at 1000 g for 2 min at
4C. Supernatants were transferred to a new tube. 15 ml GFP-Trap_A bead slurry were equilibrated with 1x dilution buffer
(500 mM NaCl, 1 mM MgCl2, 0.05% SDS, 0.05% IGEPAL, 50 mM Tris pH 7.5, 100 U/ml Ribolock RNase inhibitor, 0.1 mM AEBSF),
incubated with 1mg/ml E. coli tRNA for 15min and, after two washes with dilution buffer, they were added to the lysates. Themixture
was incubated for 2 h at 4C with gentle rotation and beads were recovered by centrifugation at 1000 g for 2 min at 4C. Beads were
washed twice with 100 ml of ice-cold high-salt buffer (500 mM NaCl, 20 mM Tris pH 7.5, 1 mM MgCl2, 0.05% IGEPAL, 0.1% SDS,
100 U/ml Ribolock RNase inhibitor, 0.1 mM AEBSF), three times with 100 ml ice-cold low-salt wash buffer (150 mM NaCl,
20 mM Tris pH 7.5, 1 mMMgCl2, 0.01% IGEPAL, 50 U/ml Ribolock RNase inhibitor) and resuspended in 50 ml of proteinase K buffer
(100 mM NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.5% SDS). Protein digestion was carried out by incubation with 200 mg/ml of pro-
teinase K (Invitrogen, #AM2546) for 30min at 37Cwith agitation (1100 rpm) and then raising temperature to 50C for 1 h. After centri-
fugation at 1000 g and 4C for 2min, the supernatant containing the RNAwas transferred to a low binding tube. RNAwas then purified
using RNeasy mini kit (QIAGEN, #74104) in parallel to the total RNA present in inputs. cDNA library was prepared with Superscript III
reverse transcriptase and oligo(dT)20 primer (Thermo Fisher Scientific, #18418020) following the manufacturer’s recommendations.
Finally, the presence of SINV sequences in cDNA libraries was detected by PCR using Phusion polymerase (New England Biolabs,
#M0530S) and SINV C specific primers (Table S6).
Analysis of GEMIN5 binding sites by iCLIP
In order to identify GEMIN5 binding sites on SINV RNA at a high resolution, we employed iCLIP-seq (Ko¨nig et al., 2010). 10x106
HEK293 Tet-on GEMIN5-eGFP cells were seeded in 5 sets of 3x15 cm dishes and induced for 24 h with doxycycline. Each cell
set was then infected with 10 MOI of SINV. Similar procedure was carried out for 1 set 3x15 cm dishes of control HEK293 Tet-on
eGFP cells with 8 h doxycycline induction. At 18 hpi, cells were washed with PBS 1x and UV irradiated with 150 mJ/cm2 at
254 nm. Cells were then lysed with 1 mL of lysis buffer (NaCl 100 mM, MgCl2 5 mM, Tris pH 7.5 10 mM, IGEPAL 0.5%, SDS
0.1%, Na deoxycholate 0.5%, DTT 1 mM, 0.1 mM AEBSF) and the three plates of each condition set were pooled (3 mL of final vol-
ume). Lysates were then passed through a 27G needle three times and sonicated with three cycles of 10 s, with 15 s pause between
pulses, using a Digenonde bioruptor at level M at 4C. The homogenate was centrifuged 17900 g at 4C for 10 min, and topped up to
3 mL with lysis buffer. To obtain RNA fragments of suitable length and to degrade DNA, 3 mL (replicates 1-2, control) or 1 mL (rep-
licates 3-5) of thawed lysate was incubatedwith 20 URNase I (Life Technologies, #AM2295) and 4 U Turbo DNase (Life Technologies,
#AM2238) per ml of lysate for 3 min at 37C, with 1100 rpm agitation. Subsequently, lysates were placed on ice and supplemented
with 440 U RiboLock RNase Inhibitor. 40 mL of control agarose bead slurry per ml of lysate was pre-equilibrated in lysis buffer and
resuspended in 50 ml of lysis buffer. Beads were added to the lysate and incubated for 30 min at 4C with gentle rotation. The super-
natants were then collected by centrifugation for 2 min at 4C and 2500 g, and then incubated with 40 mL of pre-equilibrated
GFP_trap_A beads per ml of lysate for 2 h at 4C with gentle rotation. Next, the beads were collected by centrifugation (2 min,
4C, 2500 g) and washed twice with 1 mL of high salt buffer (NaCl 500 mM, Tris HCl pH 7.5 20 mM, MgCl2 1 mM, IGEPAL 0.05%,
SDS 0.1%, 0.1 mM AEBSF, 1 mM DTT), twice with 1 mL of medium salt buffer (NaCl 250 mM, Tris HCl pH 7.5 20 mM, MgCl2
1 mM, IGEPAL 0.05%, 0.1 mM AEBSF, 1 mM DTT), and twice with 1 mL of PNK wash buffer (20 mM Tris-HCl pH 7.4,
10 mM MgCl2, 0.2% Tween-20) (replicates 1-2, GFP control) or low salt buffer (NaCl 150 mM, Tris HCl pH 7.5 20 mM, MgCl2
1 mM, IGEPAL 0.01%, 0.1 mM AEBSF, 1 mM DTT) (replicates 3-5). Beads were resuspended in 20 mL PNK mix [15 mL H2O, 4 mL
5x PNK buffer pH6.5 (350 mM Tris-HCl pH 6.5, 50 mMMgCl2, 25 mM DTT), 5 U of PNK enzyme (NEB, #M0201S), 20 U of Ribolock]
and incubated for 20 min, at 37C at 1100 rpm. Beads were then washed once with low salt buffer, once with high salt buffer, and
twice with low salt or PNK wash buffer. Beads were then resuspended in 20 mL ligation mix [ligation buffer (50 mM Tris-HCl,
10 mMMgCl2, 10 mM DTT), 10 U of RNA ligase (NEB, M0204S), 20 U of Ribolock, 1.5 mM pre-adenylated linker L3 (TriLink Biotech-
nologies, # T1-BGV01A), 4 mL PEG400 (Sigma-Aldrich, #202398-250G)] and incubated O/N at 16C shaking at 1100 rpm. Subse-
quently, beads were washed with 500 mL of cold low salt or PNK wash buffer and three times with 1 mL of high salt buffer. Beads
were transferred to a low binding tube during the third wash. The beads were further washed twice with 1 mL ice-cold low salt or
PNK wash buffer and resuspended in 20 mL low salt or PNK wash buffer, 1x NuPAGE loading buffer (Invitrogen, #NP0007) and
100 mM DTT and denatured at 70C (1200 rpm, 10 min). The supernatant was collected by centrifugation (1 min at 4C and
2500 g), loaded on a 4%–12% Bis-Tris NuPage gel (Invitrogen, #NP0321) and run 90 min at 150 V in 1x MOPS running buffer (Life
Technologies, #NP0001). Protein-RNA complexes were transferred to a membrane of nitrocellulose (30 V for 1 h). Region matching
190-280 kDa was then cut out, transferred to a fresh microfuge tube, topped up with 200 mL of proteinase K mix (80 mM Tris-Cl pH
7.4; 40 mMNaCl; 8 mM EDTA and 800 mg of proteinase K), and incubated for 20 min at 37C and 1100 rpm. Subsequently, 200 mL of
PKurea buffer (100 mM Tris-Cl pH 7.4; 50 mMNaCl; 10 mM EDTA; 7 M urea) was added and the sample then incubated for 20 min at
37C at 1100 rpm. RNA was then phenol/chloroform extracted as in (Huppertz et al., 2014; Ko¨nig et al., 2010). Pellets were
resuspended in 5 mL of nuclease free H2O and stored at 20C. Reverse transcription was carried out using Superscript IIIMolecular Cell 74, 196–211.e1–e11, April 4, 2019 e6
(Life Technologies, #18080-044) and unique Rclip primers as in (Huppertz et al., 2014; Ko¨nig et al., 2010). The reaction was then
transferred to a low DNA binding tube and precipitated with ethanol as in (Ko¨nig et al., 2010). The pellets were resuspended in
12 mL of 1x TBE-urea loading buffer, heated for 3 min at 80C and separated on a 6% TBE-urea precast gel (Life Technologies,
#EC6865BOX) for 40 min at 180 V. For replicates 1-2 and the control, the region of the gel corresponding to 85-200 nucleotides
was cut off the gel and placed in a 0.5 mL microtube pierced with a needle inside a 1.5 mL microtube. Samples were spun at
16000 g for 1 min, and the flow-through topped up with 400 ml of diffusion buffer (0.5 M ammonium acetate, 10 mM magnesium ac-
etate, 1mMEDTA, 0.1%SDS) and incubated at 50C for 30min. For replicates 3-5, two regions of the gel containing cDNA fragments
of 120-200 nucleotides and 85-120 nucleotides were cut off from the gel and crushed into small pieces using a pestle in 400 mL TE
buffer. The samples were then incubated for 1 h at 37Cand 1100 rpm, placed on dry ice for 2min, and incubated again for 1 h at 37C
and 1100 rpm. In all cases, the disrupted gel was then filtered by spinning through a Costar SpinX column (Sigma, #CLS8160-96EA)
by centrifugation at 16000 g. The cDNA was then extracted using phenol/chloroform as in (Ko¨nig et al., 2010). Pellets were resus-
pended in 8 mL ligation mix [1x CircLigase Buffer II; 2.5 mM MnCl2; 30 U of CircLigase II (Epicenter, #CL9025K)] and incubated for
1 h at 60C. We next added 30 mL of oligo annealing mix [25 mL H2O; 4 mL NEBuffer 4 (NEB, #B7004S); 0.3 mM cut_oligo (Sigma-Al-
drich)] and the sample was heated for 1 min at 95C followed by a temperature decrease of 1C every 40 s until reaching 25C. The
samples were then digested with 2 mL of BamHI (Thermo Fisher, #FD0054) and incubated for 30min at 37C. After incubation at 80C
for 5 min, cDNA was ethanol precipitated (Ko¨nig et al., 2010). Pellets were resuspended in 20 mL H2O and mixed with 1 mL of 10 mM
primer mix P5/P3 Solexa and 20 mL Accuprime Supermix 1 (Life Technologies, #12342-010). The libraries were then amplified for 18
cycles (replicate 1), 23 cycles (replicate 2), 25 cycles (replicates 3-5) or 30 cycles (control GFP) and the products were then analyzed
on a 6%TBE precast gel (Life Technologies, #EC6265BOX) in TBE buffer for 60min at 140 V. The gel was stained with 1x TBE plus 1x
SybrGold for 20 min (Life Technologies, #S11494) and bands of appropriate size cut out under blue light trans-illuminator. The gel
slices were dissolved with a pestle in 100 mL diffusion buffer (0.5 M ammonium acetate; 10 mM magnesium acetate; 1 mM
EDTA pH 8.0; 0.1% SDS), incubated for 30 min at 50C at 1100 rpm and filtered in a Costar SpinX column as above. The library
was purified using QIAquick Gel Extraction Kit (QIAGEN, #28704) and quantified on a Bioanalyser using a DNA high-sensitivity
chip. Libraries were pooled for sequencing and processed using single-end sequencing mode with a NextSeq 500/550 High Output
v2 kit (75 cycles, Illumina, #FC-404-2005).
Immunofluorescence and RNA FISH assays
High Precision Coverslips (Marienfeld, #0107052) were washed once in 1 M HCl for 30 min on a rocking machine, twice in double
distilled water for 10 min and once in ethanol 70% for 10 min. 150,000 cells were seeded on the dried coverslips and incubated
in DMEM with 10% FBS. In the case of the Tet-on cells, protein induction was performed with 1 mg/ml doxycycline. 16 h later cells
were either mock-infected or infected for 1 h at 37C with 10 MOI of SINV in DMEMwithout FBS, followed by the replacement of the
mediumwith DMEM supplemented with 1% FBS. At the corresponding times post-infection, cells were rinsed once in PBS and fixed
in 4%methanol-free formaldehyde for 10 min. After three 5 min washes in PBS, cells were permeabilised for 5 min with 1x PBS sup-
plemented with 0.1% Triton X-100 (PBST). Next, cells were rinsed twice in PBST and once in PBST supplemented with 2%BSA, and
blocked for 1 h with PBST supplemented with 2% BSA. Cells were later incubated for 1 h with primary antibodies (a-SINV C at 1:200
dilution or a-XRN1 at 1:50 dilution) in PBST + 2% BSA. Cells were subsequently rinsed in PBST + 2% BSA and washed three times
with PBST + 2% BSA for 10 min. Cells were then incubated for 1 h in darkness with the secondary antibodies (a-rabbit Alexa488,
a-rabbit Alexa594 or/and a-mouse Alexa488; Thermo Fisher Scientific, #A-21206, #A-21207, #A-21202 respectively) and/or GFP-
Booster_Atto488 (ChromoTek GmbH, #gba488-100) at 1:500 dilution in PBST supplemented with 2% BSA. Cells were washed
once with PBST supplemented with 2% BSA and three additional times with PBST supplemented with 2% BSA for 10 min. Cells
were incubated with 2 mg/ml of DAPI in PBS for 5 min. Finally, cells were washed twice in PBST, once in PBS for 5 min, once in
milliQ H2O and mounted on glass slides using Vectashield Antifade mounting medium (Vector Laboratories, #H-1000).
For combined immunofluorescence and RNA FISH, cells were seeded in coverslips and fixed and permeabilised as described
above. Then, cells were rinsed three times in PBST and incubated for 1 h with primary antibody (a-SINV C at 1:200 dilution) in
PBST + 0.5 U/ml RiboLock RNase inhibitor. Next, cells were washed once in PBST and three additional times with PBST for
10 min. Cells were then incubated with secondary antibody (a-rabbit Alexa488 at 1:500 dilution) in PBST supplemented with
0.5 U/ml RiboLock RNase inhibitor for 1 h in darkness. Cells were washed once with PBST, and two additional times with PBST
for 10 min, once in PBS for 10 min and fixed again in 4% methanol-free formaldehyde for 10 min. Cells were washed twice in
PBS for 5 min, once in 1x PBS / 1x SSC for 5 min, once with 2x SSC for 5 min and twice with pre-hybridization buffer (2x SSC
and 10% deionized formamide in DEPC water) at 37C for 10 min. Next, cells were incubated with RNA probes [2 pmol/ml oligo(dT)25
or oligo(dA)25 coupled to Alexa 594 (Life technologies Ltd), or 125 nM SINV RNAs-specific Stellaris probes (LGC Biosearch Technol-
ogies)] in hybridization buffer (2x SSC, 10% deionized formamide and 10% dextran sulfate in DEPC water) for 16 h at 37C in a wet
chamber. In the case of Tet-on cells expressing GEMIN5-eGFP or MOV10-YFP proteins, GFP-Booster_Atto488 (1:500 dilution) was
included at this step. Cells were subsequently washed twice with pre-hybridization buffer for 10 min at 37C and incubated for 5 min
at 37Cwith 2 mg/ml DAPI in pre-hybridization buffer. Finally, cells were washed twice with 2x SSC for 5 min, twice with 1x PBS, once
for 5 min with 1x PBS and once in milliQ H2O. The coverslip was mounted immediately after on glass slides using Vectashield.
In both cases, images were acquired on an API DeltaVision Elite widefield fluorescence microscope using a 100X oil UPlanSApo
objective (1.4 NA) and deconvolved with SoftWoRx v6.5.2 (GE Healthcare). Fluorescence intensity profiles were obtained using thee7 Molecular Cell 74, 196–211.e1–e11, April 4, 2019
script ‘‘Multichannel Plot Profile’’ in the BAR collection for ImageJ (https://imagej.net/BAR). In Figures 4 and S4, RBPswere classified
as ‘enriched’ when accumulating in viral factories co-localizing with SINV C; ‘absent’ when undetectable in viral factories; and
‘diffused’ RBPs when distributed across the cytoplasm and thus present but not enriched in viral factories.
Determining the percentage of infected cells
9x105 HEK293 cells were seeded on washed coverslips and incubated in DMEM minus phenol red + 5% FBS + 1 mM sodium py-
ruvate for 24 h. Cells were infected with different MOI of SINV-mCherry in complete DMEM (lacking phenol-red) with 2.5% FBS. At
18 hpi, cells were fixed and processed for immunofluorescence as indicated above using a-SINV C antibody and DAPI. Images were
acquired on an API DeltaVision Elite widefield fluorescence microscope using a 60X oil PlanApo objective (1.42 NA). The percentage
of infected cells was calculated by counting C-expressing cells and the total number of DAPI-stained cells using the ‘‘Cell Counter’’
plugin in ImageJ. To define the MOI of SINV used in cRIC experiments and fitness assays, different concentration of viruses were
tested. We selected 10 MOI for cRIC experiments because it is the minimal dose promoting high percentage of infected cells in a
reproducible manner. We selected 0.1 MOI for fitness experiments as it allows optimal measurement of the mCherry fluorescence
in the CLARIOstar plate reader.
Mass spectrometry
cRIC inputs (whole cell lysates) and eluates were processed following the filter aided sample preparation (FASP) as in (Castello et al.,
2013). GEMIN5-eGFP and eGFP IPs were processed with a single-pot solid-phase-enhanced sample preparation (SP3) protocol us-
ing 70% acetonitrile for protein binding (Sielaff et al., 2017). All samples were acidified with 5% formic acid prior to mass spectro-
metric analysis.
Peptides from the cRIC inputs, and GEMIN5-eGFP and eGFP IPs were analyzed on an Ultimate 3000 ultra-HPLC system (Thermo
Fisher Scientific) and electrosprayed directly into a QExactive mass spectrometer (Thermo Fisher Scientific). They were initially trap-
ped on a C18 PepMap100 pre-column (300 mm inner diameter x 5 mm, 100A˚, Thermo Fisher Scientific) in solvent A (0.1% [vol/vol]
formic acid in water). The peptides were then separated on an in-house packed analytical column (75 mm inner diameter x 50cm
packed with ReproSil-Pur 120 C18-AQ, 1.9 mm, 120 A˚, Dr. Maisch GmbH) using a linear 15%–35% [vol/vol] acetonitrile gradient
(2 h for whole cell lysates and 1 h for protein-protein interaction samples) and a flow rate of 200 nl/min. Full-scan mass spectra
were acquired in the Orbitrap (scan range 350-1500 m/z, resolution 70000, AGC target 3 3 106, maximum injection time 50 ms) in
a data-dependent mode. After the mass spectrum scans, the 20 (for whole cell lysates) or 10 (GEMIN5 IPs) most intense peaks
were selected for higher-energy collisional dissociation fragmentation at 30% of normalized collision energy. Higher-energy colli-
sional dissociation fragmentation spectra were also acquired in the Orbitrap (resolution 17500, AGC target 53 104, maximum injec-
tion time 120 ms) with first fixed mass at 180 m/z.
For cRIC eluates, liquid chromatography (LC) was performed using an EASY-nano-LC 1000 system (Thermo Fisher Scientific) in
which peptides were initially trapped on a 75 mm internal diameter guard column packed with Reprosil-Gold 120 C18, 3 mm, 120 A˚
pores (Dr. Maisch GmbH, #r13.9g) in solvent A using a constant pressure of 500 bar. Peptides were then separated on a 45C heated
EASY-Spray column (50 cm x 75 mm ID, PepMap RSLC C18, 2 mm, Thermo Fisher Scientific #164540) using a 3 h linear 8%–30%
[vol/vol] acetonitrile gradient and constant 200 nl/min flow rate. Peptides were introduced via an EASY-Spray nano-electrospray
ion source into an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific). Spectra were acquired with resolution 30000, m/z
range 350-1500, AGC target 1x106, maximum injection time 250 ms. The 20 most abundant peaks were fragmented using CID
(AGC target 5x103, maximum injection time 100 ms, normalized collision energy 35%) in a data dependent decision tree method.
Peptide identification and quantitation of all proteomics experiments was then performed using MaxQuant (v1.5.0.35) (Cox and
Mann, 2008). Data were searched against the Human Uniprot database (version, January 2016) alongside a custom database
including all the known SINV polypeptides and a list of common contaminants provided by the software. eGFP protein sequence
was included in the analysis of GEMIN5-eGFP and eGFP IPs (Uniprot ID C5MKY7). The search parameters for the Andromeda search
engine were: full tryptic specificity, allowing two missed cleavage sites, fixed modification was set to carbamidomethyl (C) and the
variable modification to acetylation (protein N terminus), oxidation (M). Match between runs was applied. All other settings were set
to default, leading to a 1% FDR for protein identification. Raw and processed proteomic data have been deposited to the
ProteomeXchange Consortium (Deutsch et al., 2017) via the PRIDE partner repository with the dataset identifier PXD009789.
RNA sequencing
RNA from the ‘inputs’ (whole cell lysate) of cRIC experiments was extracted using TRIzol. Strand-specific RNA-seq was performed
with 100 ng of total RNA. Libraries were prepared using NEBNext Ultra Directional RNA library Prep Kit for Illumina (New England
Biolabs, #E7420S) according to manufacturer instructions. In brief, RNA was fragmented for 15 min at 94C and then reverse tran-
scribed. cDNA and double-stranded cDNA was purified with AMPure XP beads (Beckman Coulter, #A63881). After end repair,
NEBNext Adaptors for Illumina (New England Biolabs, #E7335S) were ligated onto the cDNA according to the kit manual. Libraries
were amplified by 15 cycles of PCR. We used the following combination of barcodes for sample multiplexing: S1_Mock ATCACG,
S1_SV4h CGATGT, S1_SV18h TTAGGC, S2_Mock ACAGTG, S2_SV4h CAGATC, S2_SV18h ACTTGA, S3_Mock GATCAG,
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NextSeq instrument, using 78 nt paired-end sequencing mode with a NextSeq 500/550 High Output v2 kit (150 cycles, Illumina #FC-
404-2002). Raw and processed RNA-seq are available at GEO: GSE125182.
QUANTIFICATION AND STATISTICAL ANALYSES
Proteomic quantitative analysis
To compare the cRIC inputs and eluates under different conditions, peptide intensity ratios between two samples were computed
and summarized. The log2-intensity ratio of each protein was tested to be different from zero in the three biological replicates using
moderated t test, which is implemented in the R/Bioconductor package limma (Smyth, 2004). p values were corrected for multiple
testing by controlling the false discovery rate with themethod of Benjamini-Hochberg. For proteins for which the protein intensity was
‘zero’ in one of the two conditions, we applied a semiquantitative approach that assumes that proteins without quantitative informa-
tion are below the detection limit (Sysoev et al., 2016). The approach compiles the number of replicates in each condition in which a
given protein has an intensity value. When comparing 2 conditions and three biological replicates, this leads to a matrix with 16
different groups (detected 0, 1, 2 or 3 times in condition 1 versus detected 0, 1, 2 or 3 times in condition 2). A protein is classified
as ‘altered RBP’ by the semiquantitative method if an intensity value is assigned to it in 3 or 2 of the replicates in one of the two con-
ditions, while only 1 or 0 intensity values are detected in the other condition.
The fraction of RNA-bound RBPs was determined by computing the ratio between the protein intensity of each individual RBP in
the cRIC eluates and that in the whole cell lysate (Figure S3D). Hence, this calculation reflects amount of protein crosslinked to RNA
(cRIC eluates) divided by the total amount of protein (cRIC inputs).
Results were visualized using the R package ggplot2 (Wickham, 2009). To assess the scope of previously known RBPs within
the RBPome of uninfected and SINV-infected HEK293 cells, proteins identified by cRIC here were compared to those
compressing the superset of human RBPs reported in (Hentze et al., 2018). GO annotations were obtained from the R package
mRNAinteractomeHeLa (http://www.hentze.embl.de/public/RBDmap/) (Castello et al., 2012) (Key Resources Table), and gene set
enrichment analysis was performed by applying Fisher’s exact test to categories of GO annotations with at least three annotated
proteins.
We compared the repertoire of RBPs with differential RNA-binding activity at 18 hpi (Table S1) with the mouse ribo-interactome
(Table S2) (Simsek et al., 2017). Specifically, we considered proteins in the Table S3 of (Simsek et al., 2017) with negative predictive
values (NPV)R 0.99 in puromycin and RNase samples as ‘ribosome-associated proteins’, as described in that study. To find mouse
orthologs for RBPs responding to SINV infection, we used the R package biomaRt to identify ENSEMBL peptide IDs for our RBPome
dataset and hom.Hs.inp.db (Carlson and Pages, 2015) to provide mapping between human and mouse proteins using these IDs
(Key Resources Table). If a mouse ortholog of an altered RBP identified at 18 hpi was found in the ‘ribo-interactome’
(Simsek et al., 2017) or if the gene symbols between human and mouse matched directly, the human RBP was considered as ‘ribo-
some-associated’. Results of this analysis are provided in Table S2.
For GEMIN5 protein-protein interaction analysis, protein quantificationwas performed by label free quantification usingMaxQuant.
Ratios were compiled and normalized to eGFP protein intensity in each sample, which is expected to be the same across samples.
Significance of the fold changes was estimated by t test using the software Perseus (Tyanova et al., 2016). We performed three main
comparisonswith the data from the IPs: i) GEMIN5-eGFP versus eGFPboth in uninfected cells; ii) GEMIN5-eGFP versus eGFP both in
SINV-infected cells; and iii) GEMIN5-eGFP in uninfected cells versus GEMIN5-eGFP in SINV-infected cells (Figure 7C, left, middle
and right, respectively). Resulting data are summarized in Table S5. Raw and processed proteomic data from GEMIN5-eGFP IPs
have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD009789.
The R package ggplot2 was utilized to visualize GEMIN5-eGFP proteomics data in volcano plots (Figures 7C). Only proteins that
were identified as high-confidence interactors of GEMIN5-eGFP (i.e., p value < 0.01 and positive log2 fold change) in the left panel of
Figure 7C were displayed in the comparison between infected and uninfected cells in the right panel. Proteins with names starting
with ‘RPS’ or ‘RPL’, were classified as ‘ribosomal’ and displayed in the volcano plots as pink dots.
STRING (Szklarczyk et al., 2017) was used to display the connectivity between altered RBPs in SINV-infected cells (Figures S2C
and S2D) and between the proteins comprising the GEMIN5 interactome (Figure S7D). Protein networks were generated using the
following parameters: display – confidence; Interaction sources – experiments and databases; interaction score – high-confidence
(0.700). Disconnected nodes were hidden from display and nodes colored based on functional enrichment within the network as
determined by STRING. GEMIN5 protein interactome (Figure S7D) was defined as proteins enriched in GEMIN5-eGFP IPs over
eGFP IPs with p value < 0.01. STRING-based GO enrichment for GEMIN5 protein interactome is provided in Table S5.
RNA sequencing data analysis
Wecombined the human genome (version hg38) with SINV sequence as our reference genome. RNA-seq readswere thenmapped to
this reference genome using STAR (Dobin et al., 2013). Reads mapping to each transcript were counted with featureCounts in Sub-
read software package (Liao et al., 2013). Only uniquely mapped reads are considered for counting. SINV infection is known to shut
off transcription globally (Gorchakov et al., 2005), which may bias (underestimate) differential expression results if normalization is
carried out assuming that overall RNA abundance remains unchanged. Therefore, we decided to normalize reach counts in each
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(0.899, 1 and 0.473 for Mock, 4 hpi and 18 hpi respectively). We confirmed by RT-qPCR that rRNA does not change in abundance in
course of infection. The R package DESeq2 (Love et al., 2014) was used for differential gene expression analysis based on rRNA
normalized read counts. As DESeq2 requires the reads counts to be un-normalized and in the form of integer values, rRNA normal-
ized read counts were rounded to the closest integer to make the ‘‘DESeqDataSet’’ to start the differential analysis. We estimated the
size factor of each sample separately in DESeq2, instead of pooling all the samples prior to estimating this parameter.
Differential RNA expression between infected (4 and 18 hpi) and uninfected cells was visualized in MA plots (Figures 3F and 3G)
using DESeq2. To visualize the overall effect of experimental covariates and potential batch effects, a principal component plot of the
samples was generated using the plotPCA function in DESeq2, based on the principal component analysis (PCA) of the variance sta-
bilized expression of the top 500 genes with the highest expression variance among samples. As shown in Figure S3F, the variance
explained by the first and second PC (on X and Y-axes) combined accounts for a high percentage (96%) of the total variance, and
samples within the same condition clustered better between them than with the other two conditions. It is interesting to note that the
first PC along accounts for 94%of the total variance, and it distinctly separates 18 hpi to the other samples (i.e., uninfected and 4 hpi),
indicating that the cellular transcriptome is dramatically altered at 18 hpi.
Genes related to GO terms ‘Response to virus’ (GO:0009615) and ‘Defense response to virus’ (GO:0051607) were extracted from
‘‘hsapiens_gene_ensembl’’ dataset (GRCh37) from Bioconductor package biomaRt (Durinck et al., 2009) and plotted as a heatmap
using the R package pheatmap (Kolde, 2015) (Figure S1E). This package was also used to make a heatmap for differentially ex-
pressed cellular RNAs, including those transcripts passing the following thresholds: i) log2 fold change > 3 or < 3 and ii) adjusted
p value < 0.01 (Figure S3E).
Reads mapping to positive and negative strands of viral RNAs were separated using SAMtools view utility (Li et al., 2009). In Illu-
mina reverse paired end sequencing, paired reads came fromopposite strands. Therefore, readswith the second pair mapping to the
positive strand, or with the first pair mapping to the negative strand, were both counted as mapping to the positive strand and vice
versa. The total read counts mapping to each strand were compiled and counted using SAMtools merge and SAMtools depth,
respectively.
Analysis of RNA synthesis, processing, and degradation
We used analysis of variance (ANOVA) to evaluate in what extent the changes in transcript levels are explained by the rate of RNA
synthesis, processing and degradation. Themeasurement of the rate of these RNA processes for each individual RNAwere obtained
from (Mukherjee et al., 2017). We built a multiple linear regression using the rate of the above-mentioned RNA processes as ‘predic-
tors’ or ‘factors’, and the transcriptome changes in SINV infected cells as the ‘response variable’.
Ti=A0i+A1iDi+A2iPi+A3iSi+Ei
i indicates all the individual RNAmolecules; Ti is the expression change for themolecule between the two conditions compared; A0i is
the regression intercept; Di, Pi and Si are the rate of degradation, processing and synthesis, respectively; Ei is the ‘error term’ in the
multiple linear regression.
After fitting the model, the total variance explained, or R-squared, is defined as the sum of squares (SS) contributed to the total SS
by different factors, i.e., the three predictor variables and the error term, as indicated in the equation below:
SStotal=SSDegration+SSProcessing+SSSynthesis+SSerror
Therefore, the contribution of the three predictors to the alterations in the transcriptome can be measured by their proportion of SS.
The partial SS for each predictor is obtained using the ‘‘sequential sum of squares’’ method implemented in ANOVA function in R
(Key Resources Table). These data (mock compare to 4 hpi and mock compare to 18 hpi) are shown in Figure 5A. A more detailed
description of ANOVA can be found in NIST/SEMATECH e-Handbook of Statistical Methods (https://www.itl.nist.gov/div898/
handbook/eda/section3/eda355.htm).
iCLIP-seq data processing
To identify GEMIN5 binding sites on SINV RNAs, reads in the fastq files from sequencing were demultiplexed to separate the samples
according to the sample barcodes. Molecular and sample barcodes as well as trailing adaptor sequences were trimmed off. Molec-
ular barcode information was stored in the read name. Reads were then mapped to a combined human (GRCh38) and SINV genome
(pT7-SVwt) sequence using STAR. Uniquely aligned readswere then extracted using SAMtools. Binding sites were determined as the
50-most base of each uniquely mapped read. PCR duplicates were identified as reads with the samemapping position andmolecular
barcode and each unique fragment counted just once. The 50-most base in sequenced reads corresponds to the base directly 30 of
the crosslinked base. The number of unique fragment counts per position gives a measure of GEMIN5 interaction strength with that
position along the RNA.
Due to the sheer abundance of SINV RNA at 18 hpi, some background signal could be observed in GFP control. To account for this
background, GFP signal was subtracted from GEMIN5 signal after correction to total SINV reads. Signal along SINV was then visu-
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Because the binding sites are narrow (sharp) and hence difficult to see when plotting the full SINV region, the plot shows an average
over a sliding window of 20 nt. Note that the negative signal from y axis (higher signal in GFP) is cut off to better highlight GEMIN5
enriched regions.
Significantly crosslinked sites were determined using iCount peaks (Key Resources Table). iCount peaks was run to generate a
background distribution by randomly distributing the crosslinked sites a hundred times along the SINV genome and compare the
actual observed distribution to this background to generate a false discovery rate. Since regions corresponding to genomic, subge-
nomic and 30 end region have different overall abundance, they were indicated as individual gene segments in the calculation to ac-
count for potentially higher background. Sites meeting FDR cutoff of 0.01 within 5 nt of each other were then merged using iCount
clusters to form binding sites. Binding sites were then given a ‘strength score’ calculated as counts within the binding site divided by
its width, and visualized in a heatmap in five bins to differently highlight the strengths of binding at different sites (Figures 7 and S7).
This process was done for the GEMIN5 replicates separately as well as for the library size normalized average of the five replicates.
Figure 7D additionally shows a heatmap that indicates how many replicates support a genomic position as binding site when deter-
mined individually per replicate. ggplot2 was used to facilitate plotting the heatmaps.
To look at base composition around the start of the SINV sgRNA, the 50-most base of unique fragments was extracted from aligned
reads taking softclipping into account. Count per base relative to total count in the sgRNA region is show in Figure S7H to indicate
relative binding site frequency and whether the sequenced base matches the genome.
Raw and processed iCLIP-seq data are available at GEO: GSE125182.
DATA AND SOFTWARE AVAILABILITY
The accession number for themass spectrometry data reported in this paper is ProteomeXchange: PXD009789. The accession num-
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